Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ANEB
ANEB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ANEB News
Anebulo Pharmaceuticals Reports Q2 Fiscal 2026 Financial Results
3d ago
seekingalpha
Anebulo Pharmaceuticals Announces Voluntary Delisting from Nasdaq
Feb 06 2026
Newsfilter
Anebulo Completes Voluntary Tender Offer for 300,000 Shares
Jan 29 2026
Newsfilter
UniFirst Corp (UNF) Receives $5.2B Acquisition Proposal from Cintas (CTAS) at 64% Premium
Dec 22 2025
Benzinga
U.S. Stocks Rise with Nasdaq Gaining Over 100 Points
Dec 22 2025
Benzinga
Biotech Stocks Rise in After-Hours Trading Driven by Data Expectations and Momentum Buying
Dec 11 2025
NASDAQ.COM
Anebulo Pharmaceuticals, Inc. Reports Q4 Loss of $2.14 Million
Sep 29 2025
NASDAQ.COM
Anebulo Pharmaceuticals Announces Financial Results for Q4 and Fiscal Year 2025 Along with Recent Developments
Sep 29 2025
Newsfilter
Anebulo Pharmaceuticals Begins Dosing First Patients in Phase 1 Study of Intravenous Selonabant for Acute Cannabis-Induced Toxicity
Sep 25 2025
Newsfilter
M&A Approval Process Explained by FCC Chair in Deal Dispatch
Sep 19 2025
Benzinga
Anebulo Pharmaceuticals Provides Update on Private Transaction and Strategic Options
Sep 12 2025
Newsfilter
Maxim Group Downgrades Anebulo Pharmaceuticals to Hold
Jul 23 2025
Benzinga
Crude Oil Falls; Thermo Fisher Scientific Earnings Top Views
Jul 23 2025
Benzinga
Dow Surges Over 200 Points; AT&T Posts Upbeat Earnings
Jul 23 2025
Benzinga
Anebulo Pharmaceuticals files to sell 15.15M shares of common stock for holders
Feb 21 2025
SeekingAlpha
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates
Feb 14 2025
Businesswire
Show More News
